| Literature DB >> 28101476 |
Abdolrahim Asadollahi1, Laleh Fani Saberi2, Ali Havasi3, Mohammad-Hossein Kaveh4.
Abstract
BACKGROUND ANDEntities:
Keywords: Epilepsy; Iran; Older adults; QOLIE-31; SF-36; Seizure; Validity & reliability
Year: 2016 PMID: 28101476 PMCID: PMC5206101 DOI: 10.14581/jer.16012
Source DB: PubMed Journal: J Epilepsy Res ISSN: 2233-6249
Frequency distribution and comparison of seniors’ demographic and background profiles by gender (n = 73, p ≤ 0.05)
| Categories | Sub Items | n | % | Male | Female | χ2/ |
|---|---|---|---|---|---|---|
| Gender | Male | 45 | 79.56 | - | - | 1.105/ 0.000 |
| Female | 28 | 20.44 | - | - | ||
| Age (Mean = 66.3, SD = 1.71) | 60–70 (young old) | 36 | 49.32 | 20 | 16 | 2.125/0.000 |
| 71–80 (middle old) | 21 | 28.77 | 13 | 8 | ||
| ≥ 81 (old old) | 16 | 21.92 | 8 | 8 | ||
| Ethnicity | Persian | 30 | 41.10 | 15 | 15 | 4.142/0.000 |
| Arab | 22 | 30.14 | 18 | 4 | ||
| Lor | 21 | 28.77 | 16 | 5 | ||
| Educational status | No formal school | 52 | 71.23 | 21 | 31 | 12.5/ 0.000 |
| Only reading | 17 | 23.29 | 10 | 7 | ||
| Primary | 2 | 2.74 | 2 | 0 | ||
| Middle school | 1 | 1.37 | 1 | 0 | ||
| High school | 0 | 0.00 | 0 | 0 | ||
| Graduated | 1 | 1.37 | 1 | 0 | ||
| Marital status | Divorced | 1 | 1.37 | 1 | 0 | 32.4/0.000 |
| Widowed | 21 | 28.77 | 7 | 14 | ||
| Separated | 0 | 0.00 | 0 | 0 | ||
| Married | 43 | 58.90 | 31 | 12 | ||
| Never married | 2 | 2.74 | 0 | 2 | ||
| Living with other | 6 | 8.22 | 0 | 6 | ||
| Length of married time (Mean = 29.3, SD = 3.27) [national range: Mean = 25.1 and SD = 3.1] | ≤ 10 year | 9 | 12.33 | 9 | 0 | 21.61/ 0.000 |
| 11–20 year | 15 | 20.55 | 10 | 5 | ||
| 21–30 year | 47 | 64.38 | 33 | 14 | ||
| ≥ 31 year | 2 | 2.74 | 0 | 2 | ||
| Family members (Mean = 5.7, SD = 1.34) | ≤ 5 persons | 41 | 56.16 | 20 | 21 | 23.8/ 0.005 |
| ≥ 6 persons | 32 | 43.84 | 15 | 17 | ||
| Economic support and pensioning | Nothing | 52 | 71.23 | 12 | 40 | 21.3/0.000 |
| Public | 19 | 26.03 | 10 | 9 | ||
| Private | 2 | 2.74 | 2 | 0 | ||
| Range of financial support upon urban poverty ratio | Nothing | 48 | 65.75 | 36 | 12 | 23.5/0.000 |
| ≤ 990,000 | 10 | 13.70 | 5 | 5 | ||
| 1000000–4500000 | 8 | 10.96 | 8 | 0 | ||
| 4510000–7990000 | 5 | 6.85 | 5 | 0 | ||
| ≥ 8000000 | 2 | 2.74 | 2 | 0 | ||
| Municipal zones | 1= Middle Class | 12 | 16.44 | 6 | 6 | 34.01/0.059 |
| 2= Developed | 8 | 10.96 | 5 | 3 | ||
| 3= Developed | 8 | 10.96 | 3 | 5 | ||
| 4= Undeveloped | 13 | 17.81 | 10 | 3 | ||
| 5= Undeveloped | 7 | 9.59 | 4 | 3 | ||
| 6= Middle Class | 4 | 5.48 | 2 | 2 | ||
| 7= Middle Class | 9 | 12.33 | 5 | 4 | ||
| 8= Undeveloped | 12 | 16.44 | 5 | 7 |
Based on Iranian Rials currency and 1 US$= 29060 IR Rials in 2014.
They are economically divided into three parts i.e. poor and undeveloped = 29.6% (zone 4, 5, & 8), middle class= 48.6% (zone 1, 6, & 7), wealthy and developed = 21.8% (zone 2 & 3) regarding income of citizens and urban facilities based on Provincial Report of KSCC (2011).
Frequency distribution and comparison of seniors’ clinical characteristics profiles by gender (n = 73, p ≤ 0.05)
| Categories | Sub Items | n | % | Male | Female | χ2/ |
|---|---|---|---|---|---|---|
| Type of epilepsy | Tonic-clonic | 31 | 42.47 | 17 | 14 | 21.01/0.009 |
| Partial | 20 | 27.4 | 4 | 16 | ||
| Absence | 13 | 17.81 | 10 | 3 | ||
| Others | 9 | 12.33 | 6 | 3 | ||
| Etiology | Idiopathic | 22 | 30.14 | 16 | 6 | 32.00/0.001 |
| Symptomatic | 38 | 52.06 | 15 | 23 | ||
| Cryptogenic | 13 | 17.81 | 11 | 2 | ||
| Seizure type | Absence | 7 | 9.59 | 3 | 4 | 13.8/0.001 |
| Myoclonic | 11 | 15.07 | 5 | 6 | ||
| Primarily generalized tonic-clonic | 14 | 19.18 | 6 | 8 | ||
| Simple partial | 18 | 24.66 | 11 | 7 | ||
| Complex partial | 9 | 12.33 | 8 | 1 | ||
| Secondarily generalized tonic-clonic | 14 | 19.18 | 9 | 5 | ||
| Seizure severity | Controlled | 18 | 24.66 | 10 | 8 | 22.08/0.000 |
| Low | 13 | 17.81 | 9 | 4 | ||
| Moderate | 18 | 24.66 | 5 | 13 | ||
| High | 10 | 13.70 | 7 | 3 | ||
| Very High | 14 | 19.18 | 10 | 4 | ||
| Antiepileptic drugs | Therapy withdrawn | 38 | 52.06 | 17 | 21 | 12.00/0.010 |
| Monotherapy | 24 | 32.88 | 11 | 13 | ||
| Polytherapy | 11 | 15.07 | 8 | 3 | ||
| Duration | Total = Mean: 17.02 years, Range: 2–63 year | 14.04/0.000 | ||||
| Male = Mean: 19.11 years, Range: 1–63 years | ||||||
| Female = Mean: 16.13 years, Range: 3–56 years | ||||||
Descriptive statistics and discriminative power in the QOLIE-31 of sub-scales with overall score
| Domains (Item Number) | No. of items | Mean (95%CI) | Median | SD | Cronbach’s α | KS | SV | df | |
|---|---|---|---|---|---|---|---|---|---|
| Seizure worry (11,21,22,23,25) | 5 | 54.5 (28–81) | 53 | 26.04 | 0.83 | 0.094 | 0.089 | 72 | 0.0001 |
| Overall QoL (1,14) | 2 | 53.2 (21–72) | 47 | 28.01 | 0.85 | 0.074 | 0.087 | 73 | 0.0001 |
| Emotional well-being (3,4,5, 7,9) | 5 | 58.7 (39.2–87.2) | 65 | 21.01 | 0.79 | 0.149 | 0.152 | 72 | 0.0001 |
| Energy/fatigue (2,6,8,10) | 4 | 20.0 (11.25–28.75) | 53 | 19.21 | 0.73 | 0.092 | 0.071 | 72 | 0.0001 |
| Cognitive functioning (12,15,16,17,18,26) | 6 | 50.7 (32.8–68.6) | 47 | 13.30 | 0.81 | 0.073 | 0.088 | 73 | 0.0002 |
| Medication effects (24,29,30) | 3 | 42.28 (13.86–70.7) | 33 | 22.82 | 0.87 | 0.147 | 0.133 | 72 | 0.0001 |
| Social functioning (13,19,20,27,28) | 5 | 59.84 (37.42–82.26) | 54 | 25.33 | 0.88 | 0.148 | 0.145 | 72 | 0.0001 |
| Total score | 30 | 52.5 (38–67) | 53 | 19.42 | 0.89 | 0.083 | 0.091 | 71 | 0.0001 |
The score range = 0–100. n = 73.
Kolmogorov-Smirnov test of normality.
Shapiro-Wilk test of normality.
Pearson correlations between QOLIE-31 and SF-36 sub-domains (p < 0.05)
| SF-36/QOLIE-31 | SW | OQoL | EWB | E/F | CF | ME | SF | TQoLIE |
|---|---|---|---|---|---|---|---|---|
| BP | 0.501 | 0.474 | 0.577 | 0.501 | 0.106 | 0.543 | 0.405 | 0.675 |
| GH | 0.479 | 0.438 | 0.571 | 0.469 | 0.436 | 0.589 | 0.416 | 0.723 |
| MH | 0.498 | 0.585 | 0.484 | 0.349 | 0.514 | 0.444 | 0.580 | 0.689 |
| PF | 0.478 | 0.458 | 0.371 | 0.435 | 0.446 | 0.433 | 0.414 | 0.771 |
| RE | 0.548 | 0.324 | 0.266 | 0.441 | 0.438 | 0.437 | 0.497 | 0.623 |
| RP | 0.578 | 0.458 | 0.371 | 0.435 | 0.446 | 0.533 | 0.514 | 0.771 |
| SF | 0.501 | 0.474 | 0.577 | 0.601 | 0.306 | 0.543 | 0.505 | 0.699 |
| VT | 0.479 | 0.438 | 0.471 | 0.569 | 0.486 | 0.389 | 0.516 | 0.723 |
| TSF-36 | 0.378 | 0.458 | 0.571 | 0.535 | 0.446 | 0.433 | 0.414 | 0.871 |
BP, bodily pain; GH, general health; MH, mental health; PF, physical functioning; RE, role emotional; RP, role physical; SF, social functioning; VT, vitality; SW, seizure worry; OQoL, overall quality of life; EWB, emotional well-being; E/F, energy/fatigue; CF, cognitive functioning; ME, medication effects; SF, social functioning; TQoLIE, total scores of overall QoLIE-31, TSF, total scores of SF-36.
Varimax rotated factors matrix of the QOLIE-31 (only factor loadings ≥5)
| Domain | No. of Item | Mean | SD | Components | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Factor 1 | Factor 2 | Factor 3 | Factor 4 | Factor 5 | Factor 6 | Factor 7 | ||||
| SW | 11 | 0.40 | 0.49 | 0.83 | ||||||
| SW | 21 | 0.29 | 0.46 | 0.84 | ||||||
| SW | 22 | 0.31 | 0.47 | 0.87 | ||||||
| SW | 23 | 0.31 | 0.47 | 0.83 | ||||||
| SW | 25 | 0.16 | 0.47 | 0.90 | ||||||
| OQoL | 1 | 0.29 | 0.37 | 0.88 | ||||||
| OQoL | 14 | 0.40 | 0.46 | 0.89 | 0.80 | |||||
| EWB | 3 | 0.24 | 0.40 | 0.81 | ||||||
| EWB | 4 | 0.33 | 0.49 | 0.82 | ||||||
| EWB | 5 | 0.36 | 0.43 | 0.93 | ||||||
| EWB | 7 | 0.09 | 0.47 | 0.80 | ||||||
| EWB | 9 | 0.33 | 0.48 | 0.89 | 0.80 | |||||
| E/F | 2 | 0.24 | 0.24 | 0.95 | ||||||
| E/F | 6 | 0.28 | 0.47 | 0.88 | ||||||
| E/F | 8 | 0.17 | 0.43 | 0.86 | ||||||
| E/F | 10 | 0.09 | 0.38 | 0.82 | ||||||
| CF | 12 | 0.09 | 0.28 | 0.83 | ||||||
| CF | 15 | 0.40 | 0.46 | 0.94 | ||||||
| CF | 16 | 0.24 | 0.40 | 0.90 | ||||||
| CF | 18 | 0.33 | 0.49 | 0.91 | ||||||
| CF | 26 | 0.36 | 0.43 | 0.88 | 0.80 | |||||
| SF | 13 | 0.09 | 0.47 | 0.80 | ||||||
| SF | 19 | 0.33 | 0.48 | 0.80 | ||||||
| SF | 20 | 0.24 | 0.24 | 0.81 | ||||||
| SF | 27 | 0.28 | 0.47 | 0.83 | ||||||
| SF | 28 | 0.32 | 0.47 | 0.87 | ||||||
| ME | 24 | 0.27 | 0.38 | 0.94 | ||||||
| ME | 29 | 0.31 | 0.46 | 0.92 | ||||||
| ME | 30 | 0.33 | 0.31 | 0.91 | ||||||
SW, seizure worry; OQoL, overall quality of life; EWB, emotional well-being; E/F, energy/fatigue; CF, cognitive function; ME, medication effects; SF, social function.
The goodness of fit indexes model
| Indexes | χ2 | df | χ2/df | AGFI | GFI | RMSEA | IFI | NFI | CFI |
|---|---|---|---|---|---|---|---|---|---|
| Value | 131.81 | 72 | 1.83 | 0.94 | 0.96 | 0.003 | 0.90 | 0.95 | 0.95 |